Skip to main content
Back
Watch Compare

BioCorRx Inc.

Data quality: 100%
BICX
OTC Services Health Services
$0.26
▼ $0.14 (-35.75%)
Mkt Cap: 6.09 M
Price
$0.26
Mkt Cap
6.09 M
Day Range
$0.26 — $0.26
52-Week Range
$0.20 — $0.50
Volume
20
Open $0.26
50D / 200D Avg
$0.35
26.23% below
50D / 200D Avg
$0.37
30.43% below

Quick Summary

Key Takeaways

Revenue grew 101.59% annually over 5 years — strong growth
Negative free cash flow of -2.30 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10199.51%

Growth

Revenue Growth (5Y)
101.59%
Above sector avg (19.14%)
Revenue (1Y)10301.10%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-431.50%
Op. Margin-606.04%

Safety

Debt / Equity
N/A
Current Ratio0.10
Interest Coverage-21.58

Valuation

PE (TTM)
-1.77
Below sector avg (-0.01)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (20 peers)
Metric Stock Sector Median
P/E -1.8 0.0
P/B — 3.1
ROE % — -1.5
Net Margin % -431.5 -0.3
Rev Growth 5Y % 101.6 19.1
D/E — 1.0

All Fundamental Metrics
Growth
Revenue Growth (1Y) 10301.10% Revenue Growth (3Y) 199.03%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 101.59% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 797,244.0 Net Income (TTM) -3.44 M
ROE N/A ROA -48.40%
Gross Margin N/A Operating Margin -606.04%
Net Margin -431.50% Free Cash Flow (TTM) -2.30 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.10
Interest Coverage -21.58 Asset Turnover 0.11
Working Capital -13.58 M Tangible Book Value -19.34 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.77 Forward P/E N/A
P/B Ratio N/A P/S Ratio 7.64
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -37.73%
Market Cap 6.09 M Enterprise Value 6.09 M
Per Share
EPS (Diluted TTM) -0.19 Revenue / Share 0.03
FCF / Share -0.10 OCF / Share -0.10
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 66.81%
SBC-Adj. FCF -2.74 M Growth Momentum 10199.51

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 797,244.0 7,665.0 89,160.0 213,841.0 48,272.0
Net Income -3.44 M -5.21 M -3.77 M -4.38 M -5.21 M
EPS (Diluted) -0.19 — — — —
Gross Profit — — — — —
Operating Income -4.83 M -5.12 M -3.79 M -4.70 M -5.51 M
EBITDA — — — — —
R&D Expenses 1.77 M 1.48 M 891,063.0 1.46 M 1.61 M
SG&A Expenses 3.79 M 3.61 M 2.88 M 3.41 M —
D&A 44,003.0 33,145.0 26,808.0 27,450.0 64,328.0
Interest Expense 223,850.0 776,780.0 194,041.0 150,969.0 -565,684.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.15 M 385,941.0 388,887.0 766,594.0 819,975.0
Total Liabilities 13.67 M 12.74 M 10.34 M 8.97 M 7.78 M
Shareholders' Equity -11.22 M -12.12 M -9.82 M -8.20 M -6.84 M
Total Debt — — — 0.0 —
Cash & Equivalents — — — — 592,053.0
Current Assets 814,468.0 117,996.0 187,119.0 316,910.0 228,326.0
Current Liabilities 8.31 M 8.21 M 6.43 M 5.36 M 4.39 M